Enanta Pharmaceuticals Newsroom

Enanta Pharmaceuticals (ENTA) Receives a Sell From J.P. Morgan

TipRanksNov 28 07:08 ET

Oppenheimer Maintains Enanta Pharmaceuticals(ENTA.US) With Hold Rating, Cuts Target Price to $14

Moomoo NewsNov 27 08:31 ET

Enanta Pharmaceuticals Is Maintained at Outperform by Baird

Dow JonesNov 26 11:19 ET

Enanta Pharma Analyst Ratings

BenzingaNov 26 07:53 ET

Baird Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Cuts Target Price to $20

Moomoo NewsNov 26 07:31 ET

JMP Securities Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Cuts Target Price to $21

Moomoo NewsNov 26 01:32 ET

Enanta Pharmaceuticals: Promising RSV Developments and Strong Immunology Pipeline Justify Buy Rating

TipRanksNov 26 00:49 ET

H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $27

Moomoo NewsOct 10 06:31 ET

JMP Securities Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsOct 9 01:31 ET

Buy Rating for Enanta Pharmaceuticals Amid Reduced Competition and Promising Drug Trials

TipRanksOct 9 00:57 ET

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Resmed (RMD)

TipRanksSep 27 13:32 ET

Leerink Partners Maintains Enanta Pharmaceuticals(ENTA.US) With Hold Rating

Moomoo NewsSep 27 13:31 ET

Baird Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsSep 27 13:31 ET

Enanta Pharmaceuticals (ENTA) Gets a Hold From Leerink Partners

TipRanksSep 27 13:19 ET

Enanta Pharma Analyst Ratings

BenzingaSep 27 10:50 ET

JMP Securities Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsSep 27 01:32 ET

JMP Securities Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsSep 26 16:32 ET

Enanta Pharmaceuticals Gains Buy Rating on Strong Clinical Results for EDP-323

TipRanksSep 26 16:20 ET

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Hyperfine (HYPR) and Biogen (BIIB)

TipRanksAug 11 13:03 ET

Enanta Pharmaceuticals: Hold Rating Amid RSV Pipeline Progress and Financial Caution

TipRanksAug 7 02:22 ET